Test article (video poster)September 16, 2022View Article ACME AS Video PosterNovember 03, 2021View Article Diagnostic tools in autoinflammatory syndromesNovember 10, 2020View Article IL-1 Inhibition Alters Arthroplasty RatesOctober 07, 2020View Article ACR 2020 Reproductive Guidelines – Lactation GuidanceSeptember 10, 2020View Article Treatments Differ Across Centers in Systemic JIAAugust 26, 2020View Article Canakinumab Tapering in Still's DiseaseAugust 20, 2020View Article Tocilizumab May Benefit COVID-19 PneumoniaJune 29, 2020View Article Canakinumab First FDA-Approved Therapy for Adult-Onset Still's DiseaseJune 17, 2020View Article TNR Grand Rounds – Cytokine Storm SyndromesMay 27, 2020View Article High Dose Anakinra Effective in COVID-19May 18, 2020View Article Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more × Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
ACME AS Video PosterNovember 03, 2021View Article Diagnostic tools in autoinflammatory syndromesNovember 10, 2020View Article IL-1 Inhibition Alters Arthroplasty RatesOctober 07, 2020View Article ACR 2020 Reproductive Guidelines – Lactation GuidanceSeptember 10, 2020View Article Treatments Differ Across Centers in Systemic JIAAugust 26, 2020View Article Canakinumab Tapering in Still's DiseaseAugust 20, 2020View Article Tocilizumab May Benefit COVID-19 PneumoniaJune 29, 2020View Article Canakinumab First FDA-Approved Therapy for Adult-Onset Still's DiseaseJune 17, 2020View Article TNR Grand Rounds – Cytokine Storm SyndromesMay 27, 2020View Article High Dose Anakinra Effective in COVID-19May 18, 2020View Article Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more × Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
Diagnostic tools in autoinflammatory syndromesNovember 10, 2020View Article IL-1 Inhibition Alters Arthroplasty RatesOctober 07, 2020View Article ACR 2020 Reproductive Guidelines – Lactation GuidanceSeptember 10, 2020View Article Treatments Differ Across Centers in Systemic JIAAugust 26, 2020View Article Canakinumab Tapering in Still's DiseaseAugust 20, 2020View Article Tocilizumab May Benefit COVID-19 PneumoniaJune 29, 2020View Article Canakinumab First FDA-Approved Therapy for Adult-Onset Still's DiseaseJune 17, 2020View Article TNR Grand Rounds – Cytokine Storm SyndromesMay 27, 2020View Article High Dose Anakinra Effective in COVID-19May 18, 2020View Article Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more × Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
IL-1 Inhibition Alters Arthroplasty RatesOctober 07, 2020View Article ACR 2020 Reproductive Guidelines – Lactation GuidanceSeptember 10, 2020View Article Treatments Differ Across Centers in Systemic JIAAugust 26, 2020View Article Canakinumab Tapering in Still's DiseaseAugust 20, 2020View Article Tocilizumab May Benefit COVID-19 PneumoniaJune 29, 2020View Article Canakinumab First FDA-Approved Therapy for Adult-Onset Still's DiseaseJune 17, 2020View Article TNR Grand Rounds – Cytokine Storm SyndromesMay 27, 2020View Article High Dose Anakinra Effective in COVID-19May 18, 2020View Article Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more × Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
ACR 2020 Reproductive Guidelines – Lactation GuidanceSeptember 10, 2020View Article Treatments Differ Across Centers in Systemic JIAAugust 26, 2020View Article Canakinumab Tapering in Still's DiseaseAugust 20, 2020View Article Tocilizumab May Benefit COVID-19 PneumoniaJune 29, 2020View Article Canakinumab First FDA-Approved Therapy for Adult-Onset Still's DiseaseJune 17, 2020View Article TNR Grand Rounds – Cytokine Storm SyndromesMay 27, 2020View Article High Dose Anakinra Effective in COVID-19May 18, 2020View Article Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more × Go to Top
Treatments Differ Across Centers in Systemic JIAAugust 26, 2020View Article Canakinumab Tapering in Still's DiseaseAugust 20, 2020View Article Tocilizumab May Benefit COVID-19 PneumoniaJune 29, 2020View Article Canakinumab First FDA-Approved Therapy for Adult-Onset Still's DiseaseJune 17, 2020View Article TNR Grand Rounds – Cytokine Storm SyndromesMay 27, 2020View Article High Dose Anakinra Effective in COVID-19May 18, 2020View Article Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more ×
Canakinumab Tapering in Still's DiseaseAugust 20, 2020View Article Tocilizumab May Benefit COVID-19 PneumoniaJune 29, 2020View Article Canakinumab First FDA-Approved Therapy for Adult-Onset Still's DiseaseJune 17, 2020View Article TNR Grand Rounds – Cytokine Storm SyndromesMay 27, 2020View Article High Dose Anakinra Effective in COVID-19May 18, 2020View Article Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more ×
Tocilizumab May Benefit COVID-19 PneumoniaJune 29, 2020View Article Canakinumab First FDA-Approved Therapy for Adult-Onset Still's DiseaseJune 17, 2020View Article TNR Grand Rounds – Cytokine Storm SyndromesMay 27, 2020View Article High Dose Anakinra Effective in COVID-19May 18, 2020View Article Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more ×
Canakinumab First FDA-Approved Therapy for Adult-Onset Still's DiseaseJune 17, 2020View Article TNR Grand Rounds – Cytokine Storm SyndromesMay 27, 2020View Article High Dose Anakinra Effective in COVID-19May 18, 2020View Article Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more ×
TNR Grand Rounds – Cytokine Storm SyndromesMay 27, 2020View Article High Dose Anakinra Effective in COVID-19May 18, 2020View Article Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more ×
High Dose Anakinra Effective in COVID-19May 18, 2020View Article Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more ×
Earlier Anakinra Initiation Warranted in Still's DiseaseMarch 12, 2020View Article Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more ×
Methotrexate and the Risk of Lung DiseaseFebruary 25, 2020View Article Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more ×
Tofacitinib Effective in Refractory Still's DiseaseFebruary 20, 2020View Article Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more ×
Systemic JIA-Associated Lung DiseaseNovember 26, 2019View Article Autoinflammatory Diseases at the ACR Annual MeetingNovember 18, 2019View Article Load more ×
Articles
